Two organizations have recently joined the R2D2-MH consortium:

• The Hospital for Sick Children (SickKids), is a world-renowned pediatric hospital based in Toronto, Canada. In R2D2-MH, the team of Prof. Louise Gallagher will examine genetic and environmental influences on risk and resilience in neurodiversity, including the RaDiaNT study which investigates a rare genetic condition called NRXN1 deletion.
• The University of Tartu joined R2D2-MH via the Horizon Europe Hop-On facility. In R2D2-MH, UTARTU addresses gaps in understanding risk/resilience factors for neurodevelopmental conditions (NDC) in adults. Using the Estonian Biobank, UTARTU explores genetic and non-genetic influences on NDC traits. UTARTU will also help reduce stigma via involvement of neurodiverse Estonian representatives.